Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
High-Dose Semaglutide Data A Mixed Bag For Novo Nordisk
Jan 18 2025
•
By
Joseph Haas
High-dose semaglutide meets endpoint in Phase III, but doesn't beat Zepbound, CagriSema
(Shutterstock)
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Clinical Trials
More from Therapy Areas